Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Peptides for Longevity & Bioregulator Research

Longevity peptides carry the most hype-to-evidence gap in the field. Russian bioregulator peptides (Epitalon) and mitokine peptides (MOTS-c) have biological rationale. Controlled human lifespan data does not exist for any peptide.

How peptide Targets Peptides for Longevity

No peptide has demonstrated lifespan extension in a controlled human trial. What does exist: Epitalon cohort data from Russian institutional populations showing reduced all-cause mortality at long follow-up, with methodological limitations that complicate interpretation. MOTS-c preclinical data in aged mice shows improved healthspan markers (exercise capacity, insulin sensitivity).

The broader longevity peptide landscape includes: Thymosin α1 (immune aging), humanin, small humanin-like peptides, FOXO4-DRI (senolytic). All are preclinical or very-early-clinical. The evidence base is not in the same league as caloric restriction, exercise, rapamycin, or metformin — all of which have substantially more human data.

For someone optimizing for longevity today, the peptide category is experimental adjunct at best. The high-leverage interventions remain: maintain muscle mass, minimize visceral fat, sleep well, don't smoke, maintain social connection.

Recommended Peptides (3)

Frequently Asked Questions

Does Epitalon extend lifespan?
Russian cohort data suggests reduced all-cause mortality in institutional populations. The evidence quality does not match Western randomized-trial standards. Treat any lifespan claim as provisional.
What about rapamycin — isn't that a peptide?
No, rapamycin is a macrolide small molecule, not a peptide. It has stronger longevity evidence than any peptide but sits outside this site's scope.

Other peptide Skin Concerns

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.